SMARCA4 and acute myeloid leukemia: In colorectal cancer (CRC) [16], hepatocellular carcinoma (HCC) [17] and acute myeloid leukemia (AML) [18], BRG1 overexpression facilitates the driving of oncogenic transcriptional processes that affect the proliferative capability of cancer cells.